Immunomodulatory biomimetic nanoparticles target articular cartilage trauma after systemic administration

Post-traumatic osteoarthritis (PTOA) is one of the leading causes of disability in developed countries and accounts for 12% of all osteoarthritis cases in the United States. After trauma, inflammatory cells (macrophages amongst others) are quickly recruited within the inflamed synovium and infiltrat...

詳細記述

書誌詳細
出版年:Heliyon
主要な著者: Chiara Mancino, Anna Pasto, Enrica De Rosa, Luigi Dolcetti, Marco Rasponi, Patrick McCulloch, Francesca Taraballi
フォーマット: 論文
言語:英語
出版事項: Elsevier 2023-06-01
主題:
オンライン・アクセス:http://www.sciencedirect.com/science/article/pii/S2405844023038471
_version_ 1851924578643738624
author Chiara Mancino
Anna Pasto
Enrica De Rosa
Luigi Dolcetti
Marco Rasponi
Patrick McCulloch
Francesca Taraballi
author_facet Chiara Mancino
Anna Pasto
Enrica De Rosa
Luigi Dolcetti
Marco Rasponi
Patrick McCulloch
Francesca Taraballi
author_sort Chiara Mancino
collection DOAJ
container_title Heliyon
description Post-traumatic osteoarthritis (PTOA) is one of the leading causes of disability in developed countries and accounts for 12% of all osteoarthritis cases in the United States. After trauma, inflammatory cells (macrophages amongst others) are quickly recruited within the inflamed synovium and infiltrate the joint space, initiating dysregulation of cartilage tissue homeostasis. Current therapeutic strategies are ineffective, and PTOA remains an open clinical challenge. Here, the targeting potential of liposome-based nanoparticles (NPs) is evaluated in a PTOA mouse model, during the acute phase of inflammation, in both sexes. NPs are composed of biomimetic phospholipids or functionalized with macrophage membrane proteins. Intravenous administration of NPs in the acute phase of PTOA and advanced in vivo imaging techniques reveal preferential accumulation of NPs within the injured joint for up to 7 days post injury, in comparison to controls. Finally, imaging mass cytometry uncovers an extraordinary immunomodulatory effect of NPs that are capable of decreasing the amount of immune cells infiltrating the joint and conditioning their phenotype. Thus, biomimetic NPs could be a powerful theranostic tool for PTOA as their accumulation in injury sites allows their identification and they have an intrinsic immunomodulatory effect.
format Article
id doaj-art-5a89910dfdcc4f19aaebba8afb4bc9a6
institution Directory of Open Access Journals
issn 2405-8440
language English
publishDate 2023-06-01
publisher Elsevier
record_format Article
spelling doaj-art-5a89910dfdcc4f19aaebba8afb4bc9a62025-08-19T21:56:58ZengElsevierHeliyon2405-84402023-06-0196e1664010.1016/j.heliyon.2023.e16640Immunomodulatory biomimetic nanoparticles target articular cartilage trauma after systemic administrationChiara Mancino0Anna Pasto1Enrica De Rosa2Luigi Dolcetti3Marco Rasponi4Patrick McCulloch5Francesca Taraballi6Center for Musculoskeletal Regeneration, Houston Methodist Academic Institute, Houston, TX, USA; Orthopedics and Sports Medicine, Houston Methodist Hospital, Houston, TX, USA; Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milano, ItalyRichard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UKCenter for Musculoskeletal Regeneration, Houston Methodist Academic Institute, Houston, TX, USA; Orthopedics and Sports Medicine, Houston Methodist Hospital, Houston, TX, USARichard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UKDepartment of Electronics, Information and Bioengineering, Politecnico di Milano, Milano, ItalyOrthopedics and Sports Medicine, Houston Methodist Hospital, Houston, TX, USACenter for Musculoskeletal Regeneration, Houston Methodist Academic Institute, Houston, TX, USA; Orthopedics and Sports Medicine, Houston Methodist Hospital, Houston, TX, USA; Corresponding author.Post-traumatic osteoarthritis (PTOA) is one of the leading causes of disability in developed countries and accounts for 12% of all osteoarthritis cases in the United States. After trauma, inflammatory cells (macrophages amongst others) are quickly recruited within the inflamed synovium and infiltrate the joint space, initiating dysregulation of cartilage tissue homeostasis. Current therapeutic strategies are ineffective, and PTOA remains an open clinical challenge. Here, the targeting potential of liposome-based nanoparticles (NPs) is evaluated in a PTOA mouse model, during the acute phase of inflammation, in both sexes. NPs are composed of biomimetic phospholipids or functionalized with macrophage membrane proteins. Intravenous administration of NPs in the acute phase of PTOA and advanced in vivo imaging techniques reveal preferential accumulation of NPs within the injured joint for up to 7 days post injury, in comparison to controls. Finally, imaging mass cytometry uncovers an extraordinary immunomodulatory effect of NPs that are capable of decreasing the amount of immune cells infiltrating the joint and conditioning their phenotype. Thus, biomimetic NPs could be a powerful theranostic tool for PTOA as their accumulation in injury sites allows their identification and they have an intrinsic immunomodulatory effect.http://www.sciencedirect.com/science/article/pii/S2405844023038471Posttraumatic osteoarthritisBiomimetic nanoparticlesTheranosticsImmunomodulation
spellingShingle Chiara Mancino
Anna Pasto
Enrica De Rosa
Luigi Dolcetti
Marco Rasponi
Patrick McCulloch
Francesca Taraballi
Immunomodulatory biomimetic nanoparticles target articular cartilage trauma after systemic administration
Posttraumatic osteoarthritis
Biomimetic nanoparticles
Theranostics
Immunomodulation
title Immunomodulatory biomimetic nanoparticles target articular cartilage trauma after systemic administration
title_full Immunomodulatory biomimetic nanoparticles target articular cartilage trauma after systemic administration
title_fullStr Immunomodulatory biomimetic nanoparticles target articular cartilage trauma after systemic administration
title_full_unstemmed Immunomodulatory biomimetic nanoparticles target articular cartilage trauma after systemic administration
title_short Immunomodulatory biomimetic nanoparticles target articular cartilage trauma after systemic administration
title_sort immunomodulatory biomimetic nanoparticles target articular cartilage trauma after systemic administration
topic Posttraumatic osteoarthritis
Biomimetic nanoparticles
Theranostics
Immunomodulation
url http://www.sciencedirect.com/science/article/pii/S2405844023038471
work_keys_str_mv AT chiaramancino immunomodulatorybiomimeticnanoparticlestargetarticularcartilagetraumaaftersystemicadministration
AT annapasto immunomodulatorybiomimeticnanoparticlestargetarticularcartilagetraumaaftersystemicadministration
AT enricaderosa immunomodulatorybiomimeticnanoparticlestargetarticularcartilagetraumaaftersystemicadministration
AT luigidolcetti immunomodulatorybiomimeticnanoparticlestargetarticularcartilagetraumaaftersystemicadministration
AT marcorasponi immunomodulatorybiomimeticnanoparticlestargetarticularcartilagetraumaaftersystemicadministration
AT patrickmcculloch immunomodulatorybiomimeticnanoparticlestargetarticularcartilagetraumaaftersystemicadministration
AT francescataraballi immunomodulatorybiomimeticnanoparticlestargetarticularcartilagetraumaaftersystemicadministration